UBI Ubisoft Entertainment SA

Ubisoft Announces Collaboration with Lucasfilm Games on a New Star Wars™ Game

Ubisoft Announces Collaboration with Lucasfilm Games on a New Star Wars™ Game

  PRESS RELEASE

  

Ubisoft Announces Collaboration with Lucasfilm Games

on a New Star Wars™ Game

Award-winning studio Massive Entertainment to lead development of

a new story-driven open-world
Star Wars adventure



PARIS, FRANCE – January 13, 2021 – Ubisoft today announced it is collaborating with Lucasfilm Games on a new story-driven open-world video game set in the beloved Star Wars galaxy.

Headed by Massive Entertainment, Ubisoft’s critically-acclaimed AAA studio based in Malmö, Sweden, the project gathers some of the most experienced, innovative talent in the video games industry and will make the most of Massive’s cutting-edge technologies, including the Snowdrop engine, to deliver a groundbreaking Star Wars adventure.

“The vast Star Wars lore is an incredible source of inspiration for our teams,” said Yves Guillemot, co-founder and CEO of Ubisoft. “This is the beginning of a long-term collaboration with Disney and Lucasfilm Games, and we are pleased to be working hand-in-hand to build upon the incredible legacy of Lucasfilm to create a game that we know Star Wars fans will love.”

“Ubisoft have a unique talent for crafting immersive worlds so we’re thrilled to work with them on this project”, said Douglas Reilly, VP, Lucasfilm Games. “We are inspired by the passion and talent of the team at Massive, and together we share a vision for the type of original stories we want to tell with our players in this expansive galaxy. They have the creativity, experience, and community understanding to bring awe-inspiring authenticity, depth and innovation to this new Star Wars game.”

“In the Star Wars galaxy and beyond, we work with the best teams in the industry to create world-class games that push the boundaries of the medium,” said Sean Shoptaw, SVP, Disney Games and Interactive Experiences. “Lucasfilm Games and Massive Entertainment together can create something truly unique for our fans across the globe.”

As Creative Director for the game, Massive’s Julian Gerighty says, “This is a lore that we love, and we want to do it justice with a game and story that bring both lifelong and new fans on an immersive and outstanding journey that will stay with them for years.”

Massive is actively recruiting for the best and brightest talents to join this career defining project. Candidates interested in joining the team can apply to open positions at .

More information about the game and the release date will be shared at a later stage.

# # #

Contacts

Investor Relations

Jean-Benoît ROQUETTE



SVP Investor Relations



39



Alexandre ENJALBERT



 Senior Investor Relations Manager



  78



Press contact

Ubisoft

Joel MORANGE

Senior Manager of Corporate Public Relations, Ubisoft

Press contact

Lucasfilm Games

Joe SULLIVAN

Senior Manager, Communications for Lucasfilm Games

About Ubisoft

Ubisoft is a leading creator, publisher and distributor of interactive entertainment and services, with a rich portfolio of world-renowned brands, including Assassin’s Creed, Far Cry®, For Honor®, Just Dance®, Watch Dogs, Tom Clancy’s video game series including Ghost Recon®, Rainbow Six® and The Division®. The teams throughout Ubisoft’s worldwide network of studios and business offices are committed to delivering original and memorable gaming experiences across all popular platforms, including consoles, mobile phones, tablets and PCs. For the 2019-20 fiscal year, Ubisoft generated net bookings of €1,534 million. To learn more, please visit: . 

© 2021 Ubisoft Entertainment. All Rights Reserved. Ubisoft and the Ubisoft logo are registered trademarks in the US and/or other countries.

Lucasfilm, the Lucasfilm logo, STAR WARS and related properties are trademarks and/or copyrights, in the United States and other countries, of Lucasfilm Ltd. and/or its affiliates. © & ™ 2021 Lucasfilm Ltd. All rights reserved.

Attachment



EN
13/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ubisoft Entertainment SA

 PRESS RELEASE

Informations sur les droits de vote et les actions au 30 septembre 202...

Informations sur les droits de vote et les actions au 30 septembre 2025 Le 8 octobre 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 30 septembre 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total ...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PEGA PEGASYSTEMS INC.
PANW PALO ALTO NETWORKS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
IMAX IMAX CORPORATION
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
ZG ZILLOW GROUP INC. CLASS A
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
CRWD CROWDSTRIKE HOLDINGS INC. CLASS A
STOK STOKE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
LAC. LITHIUM AMERICAS CORP NEW
ORKA ORUKA THERAPEUTICS INC
ZBIO ZENAS BIOPHARMA INC.
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
 PRESS RELEASE

Informations sur les droits de vote et les actions au 31 août 2025

Informations sur les droits de vote et les actions au 31 août 2025    Le 11 septembre 2025 Information relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Information mensuelle au 31 août 2025(Articles L. 233-8, II, du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Date Nombre total d’actions composa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch